Treace Announces Interim Results from ALIGN3D™ Clinical Study at ACFAS 2021
Message : Required fields PONTE VEDRA, Fla., May 19, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ procedure, today announced positive interim results from the ALIGN3D™ clinical study in a podium presentation at the ongoing American College of Foot and Ank...
United States Dane Wukich Johnt Treace Triplanar Tarsometatarsal Arthrodesis Georget Liu Department Of Orthopaedic Surgery
Source: marketscreener.com